Managing A Multi-Stakeholder Writing Project
Photo by Scott Graham

Managing A Multi-Stakeholder Writing Project

Research and development in the pharma and medical device industries involve many stakeholders (e.g., regulatory affairs, clinical, biometrics, clinical pharmacology, CMC, non-clinical), and thus a regulatory document almost always has multiple authors. Writing a regulatory document with multiple collaborators can be chaotic and time-consuming. Adopting a few of the principles underlying document writing operating procedures used by pharmaceutical companies and clinical research organizations that specialize in medical writing can simplify and expedite the process.

The best practice is a process initiation meeting during which several decisions can be made:

·??????First, the document’s "owner" must be determined. This author can be, but does not have to be, the medical writer. The meaning of document ownership is that the author is responsible for coordinating the writing and review activities of the various stakeholders within the group as well as for external activities such as quality control (QC) and publishing, and submission to the regulatory authorities.

·??????The process for input resolution should be decided upon. For the most part, there should be one or more comment resolution meetings built into the timeline. In addition, there should be a stakeholder who has the authority to make the final decision on the content of the document or on specific sections of the document (e.g., the Safety Physician who has the final say on safety sections across submission documents).

·??????After choosing the document owner, areas of responsibility need to be defined. Who shall be responsible for writing each section? Sometimes, sections can be lifted as they are from source documents, but in other cases de novo text is needed. The responsibility for formulating messages and ensuring their consistency across the program documents is especially important and should be discussed in the kick-off meeting.

·??????Finally, the hardest part is making the decisions pertaining to the work process. Whenever possible, it is advisable to design a timeline comprising a series of meetings (discussion of results, comment resolution, etc.). It is important to know what the preferred mode of communication is for the group and for each collaborator, and what is the best way to communicate with them in order to receive rapid responses. A convenient solution worth considering is storage of data (including drafts) in an online repository accessible by everyone in the group. It is very important to try to get the co-authors (or at least some of them) to commit to timelines of reading and reviewing the drafts. In this context, advance knowledge of any prolonged absences of the co-authors is important and useful. In terms of the process, it is useful to hold rounds of review and revision sequentially, so that each contributor is able to see the input provided by his/her predecessors and the article owner does not have to consolidate the comments of various reviewers. For the sake of this process, it is best when notes are provided in "track changes" mode, with the reviewer's identity and time of review. If the timeline does not allow such sequential reviewing, it is best to conduct concurrent reviews on collaboration platforms such as Veeva Vault or Please Review.

Phaedra Theodoridis, PhD

Freelance Medical Writer | Biochemist | Owner of Lexi Writing

2 年

This was informative, thanks for sharing Shiri!

要查看或添加评论,请登录

Shiri Diskin的更多文章

  • How to Bring a Medical Device to Market in the United States by ChatGPT (Part 1)

    How to Bring a Medical Device to Market in the United States by ChatGPT (Part 1)

    Written by ChatGPT and edited by a Homo sapiens sapiens Medical devices play a critical role in modern healthcare, from…

    4 条评论
  • The QC Process For CSRs

    The QC Process For CSRs

    By Danielle Hadar When starting QC work on a document, I first look through the entire document and its formatting to…

    6 条评论
  • The Five KYSes for Getting the Best Out of Your Medical Writing Vendor

    The Five KYSes for Getting the Best Out of Your Medical Writing Vendor

    We often focus on what vendors should do in order to consistently deliver high-quality documents on time. There are…

    3 条评论
  • Software As A Medical Device

    Software As A Medical Device

    Introduction to software as medical device (SaMD) By Liat Laufer Digital tools and applications have become integral…

    1 条评论
  • Clinical Studies in South Africa

    Clinical Studies in South Africa

    By Anca Savulescu Between the years 2008 and 2018, South Africa was not a popular choice when considering countries for…

    1 条评论
  • CMC Considerations

    CMC Considerations

    By Cheryl Berkowitz The drug manufacturing program for a pharmaceutical product is designed to collect information to…

  • Handling Peer Review Feedback: Stay Cool, Calm, and Collected

    Handling Peer Review Feedback: Stay Cool, Calm, and Collected

    By Daniela Kamir Academic manuscripts generally require revision following initial submission. If the authors agree to…

    1 条评论
  • Introduction to CMC

    Introduction to CMC

    Introduction to CMC By Cheryl Berkowitz When new acquaintances learn that I have worked for over 10 years in the Pharma…

  • Cultivated Meat and Prospects for Regulatory Approval

    Cultivated Meat and Prospects for Regulatory Approval

    This is Part 3 of the Cultivated Meat series. If you missed Part 2, click here: Cultivated Meat and Prospects for…

    2 条评论
  • Why Cultivated Meat?

    Why Cultivated Meat?

    This is Part 2 of the Cultivated Meat series. If you missed Part 1, click here: Why Cultivated Meat? By Dionne Crafford…

社区洞察

其他会员也浏览了